Lipid peroxidation and redox-sensitive signaling pathways

Current Atherosclerosis Reports

Volumn 9, Issue 3, 2007, Pages 216-221

  Uchida, Koji ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; ARACHIDONIC ACID; CD36 ANTIGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; POLYUNSATURATED FATTY ACID; PROTEIN KINASE LYN; TRANSCRIPTION FACTOR NRF2; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT RESPONSIVE ELEMENT; AORTA ATHEROSCLEROSIS; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CYTOPATHOLOGY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIFESTYLE; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

ALDEHYDES; ANTIGENS, CD36; CYCLOOXYGENASE 2; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID PEROXIDATION; NF-KAPPA B; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PPAR GAMMA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION;

EID: 35449006744     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-007-0022-7     Document Type: Review

References (51)

1. Steinberg D, Parthasarathy S, Carew TE, et al.: Modification of low-density lipoprotein that increase its atherogenecity. N Engl J Med 1989, 320:915-924.
2. Steinberg D: Role of oxidized LDL and antioxidants in atherosclerosis. Adv Exp Med Biol 1995, 369:39-48.
3. Quinn MT, Parthasarathy S, Fong LG, Steinberg D: Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A 1987, 84:2995-2998.
4. Glass CK, Witztum JL: Atherosclerosis. The road ahead. Cell 2001, 104:503-516.
5. Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991, 11:81-128.
6. Uchida K: 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003, 42:318-343.
7. Lee SH, Blair IA: Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem Res Toxicol 2000, 13:698-702.
8. Rindgen D, Lee SH, Nakajima M, Blair IA: Formation of a substituted 1,N(6)-etheno-2'-deoxyadenosine adduct by lipid hydroperoxide-mediated generation of 4-oxo-2-nonenal. Chem Res Toxicol 2000, 13:846-852.
9. Lee SH, Oe T, Blair IA: Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 2001, 292:2083-2086.
10. Hazeu SL, Chisolm GM: Oxidized phosphatidylcholines: pattern recognition ligands for multiple pathways of the innate immune response. Proc Natl Acad Sci USA 2002, 99:12515-12517.
11. Binder CJ, Shaw PX, Chang MK, et al.: The role of natural antibodies in atherogenesis. J Lipid Res 2005, 46:1353-1363.
12. Haberland ME, Fong D, Cheng L: Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 1988, 241:215-217.
13. Palinski W, Rosenfeld ME, Ylä-Herttuala S, et al.: Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 1989, 86:1372-1376.
14. Uchida K: Role of reactive aldehyde in cardiovascular diseases. Free Radic Biol Med 2000, 28:1685-1696.
15. Kumagai T, Matsukawa N, Kaneko Y, et al.: A lipid peroxidation-derived inflammatory mediator: Identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chem 2004, 279:48389-48396.
16. Leonarduzzi G, Robbesyn F, Poll G: Signaling kinases modulated by 4-hydroxynonenal. Free Radic Biol Med 2004, 37:1694-1702.
17. Vindis C, Escargueil-Blanc I, Elbaz M, et al.: Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: Prevention by aldehyde scavengers. Circ Res 2006, 98:785-792.
18. Podrez EA, Poliakov E, Shen Z, et al.: Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem 2002, 277:38517-38523.
19. Rahaman SO, Lennon DJ, Febbraio M, et al.: A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 2006, 4:211-221.
20. Nagy L, Tontonoz P, Alvarez JG, et al.: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARg. Cell 1998, 93:229-240.
21. Shiraki T, Kamiya N, Shiki S, et al.: α,β-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor g. J Biol Chem 2005, 280:14145-14153.
22. Davies SS, Pontsler AV, Marathe GK, et al.: Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem 2001, 276:16015-16023.
23. Itoh K, Mochizuki M, Ishii Y, et al.: Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-D12,14-prostaglandin J2. Mol Cell Biol 2004, 24:36-45.
24. Murphy GJ, Holder JC: PPAR-y agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 2000, 21:469-474.
25. Bhatnagar A: Electrophysiological effects of 4-hydroxynonenal, an aldehydic product of lipid peroxidation, on isolated rat ventricular myocytes. Circ Res 1995, 76:293-304.
26. Fukuda K, Davies SS, Nakajima T, et al.: Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res 2005, 97:1262-1269.
27. Bautista DM, Jordt SE, Nikai T, et al.: TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006, 124:1269-1282.
28. Inoue T, Bryant BP: Multiple types of sensory neurons respond to irritating volatile organic compounds (VOCs): calcium fluorimetry of trigeminal ganglion neurons. Pain 2005, 117:193-203.
29. Dinkova-Kostova AT, Holtzclaw WD, Kensler TW: The role of Keap1 in cellular protective responses. Chem Res Toxicol 2005, 18:1779-1791.
30. Hosoya T, Maruyama A, Kang MI, et al.: Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem 2005, 280:27244-27250.
31. Gilroy DW, Colville-Nash PR, Willis D, et al.: Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999, 5:698-701.
32. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, et al.: Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci U S A 2004, 101:2040-2045.
33. Zhang DD, Hannink M: Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 2003, 23:8137-8151.
34. Eggler AL, Liu G, Pezzuto JM, et al.: Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc Natl Acad Sci U S A 2005, 102:10070-10075.
35. Page S, Fischer C, Baumgartner B, et al.: 4-Hydroxynonenal prevents NF-kB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J Biol Chem 1999, 274:11611-11618.
36. Ji C, Kozak KR, Marnett LJ: IkB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J Biol Chem 2001, 276:18223-18228.
37. Minekura H, Kumagai T, Kawamoto Y, et al.: 4-Hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response. Biochem Biophys Res Commun 2001, 282:557-561.
38. FitzGerald GA, Austin S, Egan K, et al.: Cyclo-oxygenase products and atherothrombosis. Ann Med 2000, 32:21-26.
39. Schonbeck U, Sukhova GK, Graber P, et al.: Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 1999, 155:1281-1291.
40. Kumagai T, Kawamoto Y, Nakamura Y, et al.: 4-Hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem Biophys Res Commun 2000, 273:437-771.
41. Chen CY, Shyu AB: Selective degradation of early-response-gene mRNAs: functional analyses of sequence features of the AU-rich elements. Mol Cell Biol 1994, 14:8471-8482.
42. Jacobson A, Peltz SW: Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu Rev Biochem 1996, 65:693-739.
43. Kumagai T, Nakamura Y, Osawa T, Uchida K: Role of p38 mitogen-activated protein kinase in the 4-hydroxy-2-nonenal-induced cyclooxygenase-2 expression. Arch Biochem Biophys 2002, 397:240-245.
44. Dean JL, Brook M, Clark AR, Saklatvaka J: p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 1999, 274:264-269.
45. Suc I, Meilhac O, Lajoie-Mazenc I, et al.: Activation of EGF receptor by oxidized LDL. FASEB J 1989, 12:665-671.
46. Liu W, Akhand AA, Kato M, et al.: 4-Hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J Cell Sci 1999, 112:2409-2417.
47. Liu W, Akhand AA, Takeda K, et al.: Protein phosphatase 2A-linked and -unlinked caspase-dependent pathways for downregulation of Akt kinase triggered by 4-hydroxynon-enal. Cell Death Differ 2003, 10:772-781.
48. Escargueil-Blanc I, Salvayre R, Vacaresse N, et al.: Mildly oxidized LDL induces activation of platelet-derived growth factor beta-receptor pathway. Circulation 2001, 104:1814-1821.
49. Mocsai A, Jakus Z, Vantus T, et al.: Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases. J Immunol 2000, 164:4321-4331.
50. Reddy ST, Wadleigh DJ, Herschman HR: Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells. J Biol Chem 2000, 275:3107-3113.
51. Hwang D, Jang BC, Yu G, Boudreau M: Expression of mitogen-inducible cyclooxygenase induced by lipopolysac-charide: mediation through both mitogen-activated protein kinase and NF-κB signaling pathways in macrophages. Biochem Pharmacol 1997, 54:87-96.